Year : 2009  |  Volume : 2  |  Issue : 1  |  Page : 65--73

Vasopressin in the pediatric cardiac intensive care unit: Myth or reality


Vishal K Singh1, Rajesh Sharma1, Amit Agrawal1, Amit Varma2 
1 Escorts Heart Institute and Research Center, Okhla Road, New Delhi, India
2 Fortis & Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi, India

Correspondence Address:
Amit Varma
Fortis and Escorts Heart Institute and Research Center Limited, Okhla Road, New Delhi - 110 025
India

Pediatric cardiac surgery is undergoing a metamorphosis, with more and more critical patients being operated in our country today. Although the principles of physiology have not changed, it is imperative that care providers continue to stay abreast with developments and newer drugs that may help modify the outcome. The team dynamics have also become more complex, which necessitates the need for all care providers (surgeons, cardiologists, anesthesiologists, and intensivists) to better understand the interactions and benefits of newer drugs. Vasopressin has been used in our adult patients for more than a decade and recently has found its rightful place in the pediatric armoury. The objective of this article is to review the physiology of vasopressin and the rationale of its use in critically ill children with shock, in context of the available published data.


How to cite this article:
Singh VK, Sharma R, Agrawal A, Varma A. Vasopressin in the pediatric cardiac intensive care unit: Myth or reality.Ann Pediatr Card 2009;2:65-73


How to cite this URL:
Singh VK, Sharma R, Agrawal A, Varma A. Vasopressin in the pediatric cardiac intensive care unit: Myth or reality. Ann Pediatr Card [serial online] 2009 [cited 2020 Apr 9 ];2:65-73
Available from: http://www.annalspc.com/article.asp?issn=0974-2069;year=2009;volume=2;issue=1;spage=65;epage=73;aulast=Singh;type=0